1 year ago
On May 4, 2022, Kymriah EMA Approval for the Treatment of Follicular Lymphoma (FL) On May 4, 2022 (Basel), Novartis announced that the European Commission has expanded the approval of Kymriah (tisa...
1 year ago
Kymriah CAR-T cell therapy demonstrates remarkable efficacy in treating relapsed or refractory follicular lymphoma On December 12, 2021, at the 63rd American Society of Hematology (ASH) Annual Meet...
1 year ago
“New Breakthrough! Chinese Medical Team’s Remarkable Results with CLDN18.2 CAR-T Therapy for Pancreatic Cancer! 🎉” Pancreatic Cancer On May 25, 2024, the Journal of Clinical Oncol...
1 year ago
FDA Approves Yescarta:From Breakthrough Therapy to Optimized Manufacturing and Broader Indications FDA Approves Yescarta for Large B-Cell Lymphoma On October 18, 2017, the U.S. FDA approved the CAR...
1 year ago
On May 27, 2022, the FDA Approved Kymriah (Tisagenlecleucel) for the Treatment of Adult Patients with Relapsed or Refractory Follicular Lymphoma (FL) After Two or More Lines of Systemic Therapy On ...
1 year ago
On May 2, 2018, FDA Approves Kymriah (Tisagenlecleucel) for Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma On May 2, 2018, the U.S. FDA approved Novartis’ CAR-T...
1 year ago
What is the Efficacy of Diffuse Large B-cell Lymphoma (DLBCL) CAR-T Treatment Diffuse large B-cell lymphoma (DLBCL) is a common aggressive hematological malignancy, with approximately 60% of patien...
1 year ago
Ключевой этап точечного лечения: Подробное объяснение афереза CAR-T для российского пациента в Шанхайской Международной больнице Жияхуи https://www.medtourcn.com/wp-content/uploads/2024/05/单...
1 year ago
Title: Key Step in Precision Treatment: Detailed Explanation of CAR-T Apheresis for a Russian Patient at Jiahui International Hospital in Shanghai https://www.medtourcn.com/wp-content/uploads/2...
1 year ago
Observation Points of the Disease After CAR-T Treatment for Lymphoma As an emerging cancer treatment, chimeric antigen receptor T-cell (CAR-T) therapy has achieved significant therapeutic effects i...
1 year ago
CAR-T Mantle Cell Lymphoma, Tecartus (Brexucabtagene Autoleucel) is Safe and Effective as the Standard Treatment for Mantle Cell Lymphoma On February 8, 2023, JCO Online published the clinical resu...
1 year ago
CAR-T Lymphoma Therapy: A Paradigm Shift in Precision Cancer Immunotherapy Lymphoma is a malignant hematopoietic system disease that threatens human health. As one of the common malignant tumors, a...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
